SHL Telemedicine 2023 Investor Presentation

SHL Telemedicine presents its 2023 annual investor results, showcasing $57.1M in revenues and operations across B2B and B2C models in three territories. The company leverages over 30 years of experience and proprietary portable 12-lead ECG technology through its SmartHeart® platform for telemedicine solutions.